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Abstract
The enzyme catechol-O-methyltransferase (COMT) metabolizes catecholamine neurotransmitters
involved in a number of physiological functions including pain perception. Both human and
mouse COMT genes possess functional polymorphisms contributing to inter-individual variability
in pain phenotypes such as sensitivity to noxious stimuli, severity of clinical pain and response to
pain treatment. In this study, we found that the effects of Comt functional variation in mice are
modality-specific. Spontaneous inflammatory nociception and thermal nociception behaviors were
correlated the most with the presence of the B2 SINE transposon insertion residing in the 3’UTR
mRNA region. Similarly, in humans, COMT functional haplotypes were associated with thermal
pain perception and with capsaicin-induced pain. Furthermore, COMT genetic variations
contributed to pain behaviors in mice and pain ratings in humans in a sex-specific manner. The
ancestral Comt variant, without a B2 SINE insertion, was more strongly associated with sensitivity
to capsaicin in female versus male mice. In humans, the haplotype coding for low COMT activity
increased capsaicin-induced pain perception in women, but not men. These findings reemphasize
the fundamental contribution of COMT to pain processes, and provide a fine-grained resolution of
this contribution at the genetic level that can be used to guide future studies in the area of pain
genetics.
Introduction
Catechol-O-methyltransferase (COMT) is an enzyme that degrades catecholamines
including epinephrine, norepinephrine and dopamine. Thus it represents a critical protein
that contributes to maintaining the homeostasis set points for a variety of diverse biological
systems including, but not limited to pain perception, mood, cognition, and responses to
both physical and emotional stressors. About a decade ago, Zubieta et al [1] reported that a
common, functional, single nucleotide polymorphism (SNP) of COMT, Val158Met,
modulates pain perception and brain responses to pain in healthy volunteers. The
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associations of this SNP with affective disorders has been an area of active investigation
since 1997 [2] and Val158Met is considered to be the main functional COMT variant. It has
been shown that the substitution from a valine (Val) to methionine (Met) at position 158
leads to a three- to four-fold reduced activity of the COMT enzyme by lowering protein
stability [3–5]. More recently, Diatchenko et al. [6] identified three common COMT
haplotypes, which further define the level of COMT activity via an effect on translation.
Although these haplotypes include the Val158Met SNP, haplotypes are associated with a
more profound change in COMT activity (up to twenty-fold difference) and correlate
strongly with variations in human pain perception [7], whereby lower enzymatic activity is
associated with higher sensitivity to painful stimuli.
In recent rodent studies, three independent laboratories have shown that in inbred mouse
strains, a Comt allele, ComtB2i, defined by the presence of 3'-UTR B2 SINE element,
affects Comt expression and multiple behaviors, including nociceptive behaviors [8–10].
The presence of the B2 SINE element is associated with higher COMT activity and,
analogous to human studies, with lower pain sensitivity.
Since the initial findings of Zubieta et al. [1], functional COMT alleles, SNPs or haplotypes,
have been examined in over 40 independent association studies of human pain [11] and have
been shown to be associated with several pain conditions including musculoskeletal pain,
fibromyalgia, orafacial pain, chronic headaches, postsurgical pain, irritable bowel syndrome
and the perception of pain evoked by multiple experimental procedures. However, not all
findings have been replicated, and not all pain conditions tested were affected (see detailed
review in Belfer & Segall [12]). The inconsistencies in the associations between COMT
polymorphisms and pain perception have been addressed by Loggia et al [14]. They showed
that the ability to detect the effect of COMT on pain processing seemed to depend on the
presence of: 1) a sufficiently robust challenge to the pain processing system and/or 2) the
recruitment of pain-inhibition mechanisms that appear to rely on CNS COMT activity. Lack
of replication, however, can also be explained by other factors related to study design and
study population [15], such as differences in age range, ethnicities, phenotyping tools, or
phenotype definitions between studies can substantially influence the results of genetic
analysis. Finally, insufficient sample size can significantly decrease statistical power to
detect true associations (for example, the study of 42 women who have undergone
mastectomy with breast reconstruction revealed only a trend but not significant association
between occurrence of persistent pain and COMT Val158Met SNP (P = 0.06 [16]).
Here, using both animal and human genetic studies, we investigate and discuss the
architecture of COMT's contribution to the basic mechanisms of pain processing. We
demonstrate that the impact of COMT on pain substantially depends on the modality of the
noxious stimulus and the individual’s sex.
Materials and Methods
Pain Modalities and Comt alleles in mice
Data from the “Heritability of Nociception Project”, which is publically available on the
Jackson Laboratory’s Mouse Phenome Database website (http://www.jax.org/phenome;
Project: Mogil 1), were used as the source data for the findings reported in this manuscript.
Twelve standard “J” inbred mouse strains were tested using a battery of common behavioral
assays of nociception. Detailed experimental methods, protocol and comparative results can
be found in previous publications [17–19] and at The Jackson Laboratory’s Mouse Phenome
Database website. For the analyses described in the studies below, we downloaded mean
data for each strain (individual data per mouse unavailable) from 20 nociception assays,
excluding data for the C57BL10/J strain because a complete data set was not available. In
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addition, data from the 129/J strain were excluded from our analysis because of the
previously identified genetic heterogeneity resulting in ~129 substrains [20]. Five of the
strains carried the mutant ComtB2i allele: A, AKR, BALB/c, C57BL/6, and SM, and five
strains carried the ancestral Comt+ allele: C3H/He, C58, CBA, DBA/2, and RIIIS.
Two to six pain assays comprised each pain modality (e.g., spontaneous responses to
inflammatory irritants, chemically-induced thermal hypersensitivity, thermal sensitivity,
mechanical sensitivity, sensitivity as measured by tail withdrawal and sensitivity to
neuropathic pain). Tail withdrawal was separated from the other thermal assays because the
tail flick is a spinally-mediated reflex, and evidence exists for an analgesic role of elevated
catacholamines within the spinal cord [33]. In each pain assay, the data reported for each
individual strain was transformed into a z-score using the formula z =(χ− μ)/ σ, where χ is
the strain mean score of the assay, μ is the mean score of all ten strains in the assay, and σ is
the standard deviation across all strains in the assay. Each strain was assigned a z-score for
each nociception assay. To determine the contribution of the ComtB2i allele to pain
sensitivity per modality, the sum z-scores obtained from summing 2–6 nociception assays in
5 strains with ComtB2i and Comt+ alleles, respectively, were tested for statistical
significance using a one-tailed, unpaired t-test (GraphPad Prism, version 5.00 for Windows,
GraphPad Software, San Diego, California USA). An overall strain z-score per strain was
calculated by summing z-scores across each pain modality, where higher (more positive)
numbers reflected higher sensitivity to pain.
Capsaicin model in male and female mice
Mice were obtained from Jackson Laboratory (Bar Harbor, ME) and bred in-house for a
limited number of generations. The following strains were used (all ‘J’ substrains): A, AKR,
BALB/c (BALB), C3H/He (C3H), C57BL/6 (B6), C57BL/10 (B10), C58, CBA, DBA/2
(D2), RIIIS, and SM.
As described by Lariviere et al. [17], mice were habituated for 30 min to observation
cylinders (30 cm diameter × 30 cm high) before being lightly restrained, injected in the
plantar hind paw with 2.5 mg capsaicin (in 20 µl of 2% dimethyl sulfoxide in saline), and
returned to the observation cylinders. The amount of time spent licking the injected paw was
measured for 15 min after injection. Strain means from male mice were presented in
Lariviere et al. [17]; data from female mice are presented here for the first time.
Capsaicin model in healthy human volunteers
University of Pittsburgh (Pitt) cohort description—The Pitt study sample consisted
of 35 healthy subjects (87.5% female; nonsmokers; 18–45 years old; self-reported ethnicity
=75.1% Caucasians, 16.6% African Americans, 8.3% Asians; 95.9% of non-Hispanic
origin).Exclusion criteria included finding spicy foods objectionable, current minor
infections (e.g., colds, or skin lesions), current acute or chronic pain, and other conditions
that may affect pain or taste sensitivity. All subjects provided informed consent, and the
University of Pittsburgh Institutional Review Board approved all study procedures.
Capsaicin (Sigma, 98%) was dissolved in 95% ethanol to 6000 ppm, and diluted to 0.004 M
and 0.0004 M in 70% ethanol; then 0.3 ml of the solution was applied to the malar surface
of the cheek in a 1 × 1 cm gauze pad covered by a self-adhesive plastic film to insure skin
contact and prevent evaporation (2 pads per concentration). A two-step increase in
concentration was used: 24 min of a low concentration (0.0004 M) followed by 22 min of a
high concentration (0.004 M). Subjects rated the sensation produced after the first minute
and thereafter every 3 min, using a standard, non-modulus, free magnitude estimation (FME;
ratings are of any number of the subject’s choice, with larger numbers indicating a more
intense sensation). Finally, a 10 cm line visual analogue scale (VAS) was used to rate the
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burn sensation experienced at the end of the 46 min and allow for scaling of the FME ratings
across subjects.
John Hopkins (JH) cohort description—The John Hopkins study sample consisted of
108 healthy adults (51.9% female; mean age = 28.61 (± 8.55SD); self-reported ethnicity
=50.9% Caucasians, 35.2% African American; 13.9% Asians; 94.4% of non-Hispanic
origin). Eligibility criteria included having no pain condition or medical disorders;
participants were excluded from participation if they had an active alcohol or drug abuse
problem or if there was present use of narcotics, antidepressants, anticonvulsants, or muscle
relaxants. All subjects provided informed consent, and the Johns Hopkins Institutional
Review Board approved all study procedures.
Capsaicin application methods were similar to procedures published previously [21–23]. A
topical cream consisting of 0.5 g of 10% capsaicin was applied to a 6.25-cm2 area on the
dorsal aspect of the right hand and was evenly spread on the skin. An occlusive dressing
(Tegederm™) was placed over the site to maintain the capsaicin within the area of
application. Since topical capsaicin-induced pain varies strongly as a function of skin
temperature [21], a contact thermode (Medoc US, Minneapolis, MN, USA), held at a
constant temperature of 38 °C, was maintained over the area. Post - application, pain ratings
gradually increased and plateaued within 30 min of applying the capsaicin [21]. Pain rating
data were collected over a 90 min interval. Participants rated their pain continuously on a
computerized 0–100 visual analog scale (0 = no pain and 100 = most intense pain
imaginable). In addition, the participants were prompted every 30 s asking whether the value
on the screen represented their current rating. This task was added to ensure that subjects
were attentive to the assessment procedures.
Thermal and pressure stimulation modelsin humans
Thermal pain phenotyping was conducted in a human cohort recruited for a case-control
study of temporomandibular joint disorder (TMD) at the University of North Carolina at
Chapel Hill as described elsewhere [51]. This cohort consisted of 198 healthy controls and
200 TMD cases identified by Research Diagnosis Criteria (RDC) exam for TMD. All
subjects in the TMD case-control study were Caucasian females, age 18–45. Subjects who
granted informed consent and supplied a sample of whole blood for DNA analysis were
included in the genetic analysis.
Quantitative Sensory Testing (QST) in this cohort was performed similarly as described
previously [51]. For thermal pain assessments, contact heat stimuli were delivered using a
computer-controlled Medoc Thermal Sensory Analyzer (TSA-II, Ramat Yishai, Israel), a
Peltier-element-based stimulator with a 15 × 15 mm surface area. Thermal threshold and
tolerance were measured on the left ventral forearm using an ascending method of limits.
Thermal pain threshold was defined as the temperature (°C) at which the participant first
perceived heat pain, whereas thermal pain tolerance was defined as the temperature (°C) at
which the participant could no longer tolerate the pain. The temperature increased from a
baseline of 32 °C with a 0.5 °C/s rate of rise until the participant responded by pressing the
button. Average thermal threshold and tolerance values were calculated from four trials used
to assess threshold values and four trials used to assess tolerance values. Individual trials
were conducted with a 30-s inter-stimuli interval at different sites of the ventral forearm.
Following heat pain assessments, the temporal summation of heat pain was assessed.
Participants were asked to rate the intensity of pain evoked by ten brief heat pulses applied
consecutively to the ventral forearm. Participants provided verbal ratings between 0–10 for
non-painful warm sensations and from 20 (representing pain threshold) to 100 (representing
the most intense pain imaginable). The ten consecutive heat pulses were delivered with a 1.5
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second interpulse interval delivered from a base temperature of 38 °C. The pulse ramp rate
was ~10 °C/second, and the peak thermal pulse duration was ~1.5 seconds. Two different
test stimuli, one set to 47 °C and one set to 50 °C, were used to generate two temporal
summation curves. The participants responses to the first initial heat pulse in a train was
used as a measure of heat pain sensitivity to suprathreshold heat pain stimuli and the verbal
responses to the first three heat pulses were used to assess the rate of rise of heat pain (i.e.,
temporal) for each train as described by Bhalanget al [51].
Pressure pain threshold (PPT) was assessed over the right and left temporali, masseter, and
trapezius muscles, temporomandibular joint (TMJ) and lateral epicondyles with a pressure
algometer (Pain Diagnosis and Treatment, Great Neck, New York, USA). The PPT was
defined as the amount of pressure (kg) at which the participant first perceived the stimulus to
be painful. Participants verbalized their responses by saying “stop” when the onset of pain
was perceived. One pretrial assessment was performed at each site followed by additional
assessments until two consecutive measures differing by less than 0.2 kg were obtained. The
maximum number of assessment at each site was five. Pressure stimuli were delivered at an
approximate rate of 1 kg/s. The cutoff pressure for all sites was 5 kg. The values from the
right and left sides were averaged to obtain one PPT value at each anatomical site.
COMT genotyping in humans
Pitt and JH cohorts—Genomic DNA was purified using QIAampTM DNA Blood Kit
(Qiagen, Valencia, CA, USA). Five COMT SNPs, rs2097603, rs6269, rs4633, rs4818, and
rs4680, were genotyped using pre-designed assays from Applied Biosysthems (ABI, Foster
City, CA). Genotyping was performed by the 5’ nuclease method [27] using fluorogenic
allele-specific probes. The PCR reaction mixture consisted of 2.5 ml Master Mixture (ABI),
100 nM detection probe for each allele, 900 nM forward and 900 nM reverse amplification
primers, and 20 ng genomic DNA in a total reaction volume of 25 ml. Allele-specific signals
were distinguished by measuring endpoint 6-FAM or VIC fluorescence intensities at 508 nm
and 560 nm, respectively, and genotypes were generated using Step One Plus System and
Software (ABI). Genotyping error rate was directly determined by re-genotyping 25% of the
samples, randomly chosen, for each locus. The overall error rate was <0.005. Genotype
completion rate was 0.98.
TMD case-control cohort—Genotyping of COMT markers was part of a larger-scale
genotyping effort where samples were genotyped on the Algynomics (Chapel Hill, NC) Pain
Research Panel, a dedicated chip-based platform utilizing the Affymetrix MegAllele
technology. The Pain Panel assesses 3,295 single nucleotide polymorphisms (SNPs)
representing 358 genes known to be involved in systems relevant to pain perception (see
method details in Smith et al [25]). Samples were dropped from the analysis for genotyping
completeness rate <0.95, or if there were discrepancies between self-reported race or sex and
genotypic results; for identified family clusters, only a single representative from each
family was included. SNPs were filtered based on call rate <0.95, discordance rate between
repeated samples >0.99, minor allele frequency < 0.01, and Hardy-Weinberg p<10−5.
Genotype completion rate in the cleaned datasets was >0.99.
Data analysis
Allele frequencies were calculated in each sample and Hardy–Weinberg Equilibrium (HWE)
test were performed using PLINK v.1.07 [28]. Single marker and haplotype analyses were
conducted for the associations between COMT markers and capsaicin-induced or thermal-
induced pain scores. All analyses were adjusted for significant. Correction for multiple
testing was not performed since only one gene was tested, and all variables are related.
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Pitt and JH cohorts
The Johns Hopkins and Pitt capsaicin-sensitivity data were combined for analysis.
Multivariable regression analysis was performed to test for association of each COMT SNP
with the dependent variable after adjustment for possible effects of covariates including
study site (JH or Pitt), age, ethnicity and sex. A p-value of 0.05 was utilized as the cut-point
for retention in the final model. Haplotype phasing and analysis was performed in PLINK
[28]; common haplotypes (frequency > 0.01) were designated as Low Pain Sensitivity
(LPS), Average Pain Sensitivity (APS), and High Pain Sensitivity (HPS) as described in [6].
Association analysis was performed between common haplotypes and dependent variables
using a generalized linear model framework modeling genetic (i.e. haplotype) and
environmental (i.e. covariates) effects simultaneously. Due to the relatively small numbers
of the HPS haplotype, a set of conditional haplotype tests were performed which tested each
haplotype separately. In these conditional haplotype tests, a test statistic was calculated from
a comparison between a null model consisting of all haplotypes, and an alternate model with
unique effects of the tested haplotype and a reference group of all other haplotypes. The
model constructed for haplotype analysis incorporated sex, age, study site and ethnicity as
covariates.
UNC TMD case-control cohort
Since the UNC cohort is a case-control study of TMD, any association test between an
intermediate phenotype (including measures of experimental pain sensitivity) and genotype
will be biased without adjusting for the case-control nature of the data. This adjustment was
performed by using weighted generalized estimating equations as described in Monsees et
al. [30]. The prevalence of chronic TMD in the population was assumed to be approximately
5%, http://www.nidcr.nih.gov/DataStatistics/FindDataByTopic/FacialPain/
PrevalenceTMJD.htm). For each association test between a pain sensitivity measure and the
COMT haplotypes, an omnibus-Wald test statistic was calculated to test the null hypothesis
that the mean paint ratings were equal in the six haplotypes. A Wald test statistic was also
calculated to test the null hypothesis that the mean rating of each specific haplotype was
equal to the mean rating of the LPS/LPS haplotype.
Results
Pain Modality-Specific Effects of Murine Comt
We first tested if the Comt SINE status is associated with pain sensitivity in a battery of
animal pain assays that constitute a number of fundamental nociceptive modalities. We
compared sensitivity in 20 nociception and hypersensitivity assays previously collected in
10 inbred mouse strains. Importantly, only data from male mice were available from the
public dataset. We organized the data into six pain modalities: spontaneous responses to
inflammatory irritants, chemically induced thermal hypersensitivity, thermal sensitivity,
mechanical sensitivity, sensitivity as measured by tail withdrawal, and sensitivity to
neuropathic pain. We calculated z-scores for each of these modalities as described above.
An overall summation of z-scores obtained from all six modalities was significantly
associated with the ComtB2i allele (p=0.025, Figure 1), such that the absence of B2 SINE
element, which codes for lower COMT activity, was associated with greater pain behaviors.
We next tested which pain modalities were responsible for this association. Strains of the
ComtB2i allele were significantly less sensitive to pain in the spontaneous responses to
inflammatory irritants modality (p=0.0005, Figure 1). Five out of 6 pain tests contributing to
this overall significance were associated with SINE element with p < 0.05, and the early
phase of formalin-induced pain was marginally insignificant (p = 0.07, Supplementary Table
1, Supplementary Figure 1). Near significance was also found for thermal nociception (hot
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plate and Hargreaves tests; p = 0.0595; Figure 1) where latency of heated hindpaw
withdrawal in Hargreaves test was independently significantly and associated with the
presence of the B2 SINE element (p = 0.03, Supplemental Table 1). While significance was
not found with other modalities, an overall trend was observed such that the mean pain z-
score of five mice strains with the ComtB2i allele was lower, signifying less pain behavior,
than the mean of five strains with the ancestral Comt+ allele. An exception was observed,
however, for the relationships with neuropathic pain (Figure 1).
Sex-Specific Effects of Murine Comt
We then examined the effects of sex on the Comt contribution to murine pain phenotypes.
Whereas the “Heritability of Nociception” series reports results from only male mice, we
conducted an independent study with both male and female standard inbred mice using the
capsaicin pain model, one of the assays in the spontaneous inflammatory nociception
modality.
We examined correlations between the presence or absence of the ComtB2i allele with mean
capsaicin-induced pain response (Figure 2), and assessed the genetic correlation among
inbred strains to determine if males and females share a similar sex-related genetic
determination [49, 50]. In females, the relationship between the ComtB2i allele and
capsaicin-induced pain is clear and highly significant, such that strains that are B2 SINE-
negative are more sensitive: Spearman r = 0.87 and Pearson r = 0.80, both are statistically
significant (p < 0.05, one-tailed t-test). A general linear model (GLM) applied to individual
data with strain nested within the ComtB2i allele confirmed this pattern and found a highly
significant main effect of the ComtB2i allele in females (p < 0.004). In males, however,
capsaicin licking and presence of the ComtB2 allele were only modestly related: Spearman r
= 0.52 and Pearson r = 0.48, both are not statistically significant, with no significant main
effect of the ComtB2i allele on capsaicin pain sensitivity (GLM, p = 0.14). Thus, these
results indicate that while the ComtB2i allele can have a significant effect on capsaicin pain
regardless of sex (GLM with both sexes: sex effect, p = 0.51, ComtB2i allele effect, p =
0.03), the heritable differences among strains are highly related to the ComtB2i allele in
females, but not in males.
Association of human COMT variants with capsaicin-induced pain
We next tested whether the murine findings are also applicable for human pain sensitivity.
The sensitivity to capsaicin-induced pain, which is an assay in the Spontaneous
Inflammatory Nociception modality in mice, was measured in humans. In the combined (Pitt
+ JH) cohort no single SNP was associated with pain scores (Supplementary Table 2). The
Val158Met SNP showed a trend towards lower post 30 min pain ratings in subjects with one
or more A alleles (p = 0.07, Beta = −6.75). This result is in the opposite direction than
expected because lower COMT activity associated with the Met substitution should lead to
greater pain sensitivity.
A significant effect of the HPS and APS haplotypes was observed at the post 30 min time
point (p = 0.04 for both, adjusted means 67.8 and 57.5 respectively; Figure 3, Table 1). The
LPS haplotype was not significantly associated with capsaicin-induced pain in this cohort.
Subjects carrying the HPS haplotype showed the greatest difference and were the most
sensitive to capsaicin. This effect was significant for females (p = 0.04 and p =0.02, adjusted
means 69.8 and 56.9, respectively), but not for males (p = 0.43 and 0.54, respectively). It is
also evident from the analysis that males did not contribute to the overall significance of the
association, consistent with effect of the sex of mice on Comt contribution to pain in mice.
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Association of human COMT variants with thermal and pressure pain
The association between thermal and pressure stimuli with COMT genotypes in a human
cohort of healthy volunteers was also examined.
Similar to what was observed for the responses to capsaicin-induced pain, no SNP in the
COMT central haploblock (Supplementary Table 3) was significantly associated with pain
scores, including the Val158Met SNP. It should be noted that only SNPs rs6269 and rs4633
were analyzed in this cohort because the other two SNPs that define the central COMT
haploblock [6, 7] did not pass genotyping QC. However, because SNPs rs6269 and rs4818
and SNPs rs4633and rs4680 are in perfect linkage disequilibrium in Caucasians [7], a
comprehensive assessment of the haploblock and Val158Met was still possible with SNP
rs4633 used as a marker of Val158Met variation. SNP rs165599 was associated with the
thermal pain ratings to the initial first pulse from the train of 10 pulses delivered at 47 °C (p
= 0.02) or 50 °C (p = 0.04). This suggests that this SNP contributes to the variation in
responses to thermal pain sensitivity in humans, which is consistent with the modifying
effect of the genetic structure of the 3’UTR of COMT in the central haploblock [52].
Next, we constructed the three major haplotypes for the central COMT haploblock using
SNPs rs6269 and rs4633 (Table 2, Supplementary Tables 4,5). In general, no association
was observed between COMT haplotypes and the pressure pain algometer ratings. However,
it is interesting to note that the HPS/HPS haplotype was slightly more sensitive than the
LPS/LPS haplotype for pressure pain ratings obtained from the masseter muscle (mean
difference = −0.52, p = 0.04). No other significant associations were observed between any
of the pressure pain algometer ratings and COMT haplotypes.
The Wald test for testing the null hypothesis of no association between COMT haplotype
and the thermal threshold rating was strongly significant (p < 0.0001). The HPS/HPS
haplotype showed significantly greater sensitivity than the LPS/LPS haplotype (mean
difference = −1.49, p<0.0001). None of the other haplotypes were significantly different
from the LPS/LPS haplotype. The Wald test for testing the null hypothesis of no association
between COMT haplotype and the responses to repeated thermal stimuli thermal pain
ratings was significant for first-pulse response at both 47 °C (p = 0.02) and 50 °C (p =
0.0008). Closer examination revealed that participants with the HPS/LPS haplotype had
significantly higher pain ratings than participants with the LPS/LPS haplotype at both 47
degrees (mean difference = 22.3, p = 0.002) and 50 °C (mean difference = 29.9, p = 0.0006).
The pain ratings of the participants with the other COMT haplotypes were not significantly
different from those of the participants with the LPS/LPS haplotype at either temperature.
No association was observed between COMT haplotype and thermal pain tolerance or
temporal summation, defined as difference between maximum VAS response and VAS
response to first heat pulse [51], in responses to repeated thermal stimuli at either 47 °C or
50 °C.
Discussion
Pain modality-specific effect of COMT functional variants on pain
In this set of investigations, we found that the effects of COMT functional variants strongly
depend on the modality of the pain test. This can be systematically observed in the results of
testing the laboratory inbred mouse strains in a battery of common assays of nociception.
We observed the strongest association among all pain modalities for the spontaneous
responses to inflammatory irritants modality (p < 0.001, Figure 1, Supplementary Table 1).
Four out of five pain tests comprising this modality were independently associated with the
presence of the ComtB2i allele, and the fifth assay approached significance. In all cases of
this modality, the presence of the ComtB2i allele was associated with a lower pain response,
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reinforcing the statistical significance of combined test. A strong trend toward significance
was observed between the ComtB2i allele for the thermal sensitivity modality (p = 0.06,
Figure 1). Among the two pain tests contributing to the thermal sensitivity modality, one
was independently associated with the ComtB2i allele. The majority of remaining assays
showed a similar directionality of the genetic effect although none were statistically
significant. In all cases, the presence of the ComtB2i allele was correlated with less pain,
with the exception of sensitivity to neuropathic pain. Importantly, only data from male mice
were available from the public data base and as demonstrated in our study, COMT activity
had a stronger contribution to pain phenotypes in females than in males, at least for
capsaicin-induced pain. Consequently, if female mice were tested in this study we could get
a stronger association with thermal pain sensitivity, which approached significance in the
present analysis.
Similarly to rodent studies, COMT functional haplotypes were associated with capsaicin-
induced pain responses in humans. Importantly, the direction of the association was
consistent between the species – with the HPS haplotype, coding for the lowest COMT
activity, associated with the highest sensitivity to noxious stimuli. Furthermore, in the UNC
human cohort that has been characterized for several noxious stimuli, the sensitivity to
thermal stimuli was strongly associated with COMT haplotypes, marginally to pressure
muscle pain and was not at all associated with temporal summation of heat pain. These
human data reinforce the results from murine experiments that the strongest effect of COMT
is on the chemical/inflammatory and sensitivity to thermal pain. It is important to recognize
that capsaicin pain and thermal stimuli initiate pain through partially shared cellular
pathways as they both activate TRPV1 receptor; this is not true for other tests contributing to
the spontaneous inflammatory nociception modality.
Since human pain perception is a mosaic of integrated components in domains affected by
COMT polymorphisms (e.g., sensory–discriminative, aversive-affective and cognitive-
evaluative), this gene can be viewed as an obvious candidate in genetic association studies
of human pain, which can explain a portion of the inter-individual variability in pain
perception, sensitivity, persistence and analgesic efficacy [12]. However, several studies
have reported negative results [31, 32]. While it is unclear if these negative findings were
caused by sample heterogeneity, missing genetic data from functional haplotypes or other
design-related issues, the modality-dependent COMT effects observed here provide a new
perspective on the inconsistencies of previous studies. Recently, we described the
dichotomous effects of COMT in neuropathic vs. nociceptive pain modalities due to
selective adrenergic signaling [33].The exact mechanism of the greater contribution of
COMT functional variation to inflammatory and thermal nociception modalities is unclear
and further studies are warranted. It may reflect a complex interplay of the differential
contributions of enhanced peripheral and central nervous system driven by adrenergic versus
dopaminergic signaling that results from low COMT activity [34].
Sex-specific effect of COMT functional variants on pain
Another novel finding of this study was the identification of significant sex differences in
the effect of Comt genetic variants on capsaicin-induced pain in mice and humans. Overall,
low COMT activity (as determined by gene functional variants) contributed stronger to
capsaicin-induced pain in females compared to males in both species.
There is a growing body of evidence that COMT’s effects are sexually dimorphic [35]. In
inbred strains of mice, female mice have lower Comt RNA expression [8]. Human COMT
activity in erythrocytes [36] and the liver [37] is lower in females, possibly because
estrogens down regulate COMT expression [38]. In human postmortem prefrontal cortex,
COMT activity is 17% lower in females than in males [39]. In human genetic studies, a
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lower prevalence of non-migrainous headache was found among women who were
homozygotes for Val/Val genotype, but not among men [40].
In general, there are three major scenarios of sex-specific differences in the effect on of a
gene on a trait or behavior: sex-specific effects (COMT affects only one sex), sex-biased
effects (COMT affects both sexes but to different degrees), and sex-antagonistic effects
(COMT affects both sexes but in opposite directions) [41]. Furthermore, the particular gene
× sex interaction may be pain modality-specific. Sex-specific effects of COMT are usually
attributed to its transcriptional regulation by estrogens [38, 42]. However, additional
mechanisms may be equally important. We propose two plausible explanations for the sex
differences in COMT’s effect on pain: 1) compared to males, females have lower COMT
levels, and both protein levels [37, 43] and COMT activity are under estrogen regulation.
Therefore, females may be primed towards more pain sensitivity; 2) males have additional
receptor pathways stimulated by catecholamines that are not as functional in females,
resulting in differences in physiological responses to stressors that act to suppress pain
processing (e.g., blood pressure responses) [44]. In the latter case, COMT polymorphisms
will have mixed contributions to pain sensitivity, resulting in the absence of significant
associations in males, as was recently demonstrated in a Chinese population sample [45].
Replication of previous association results
Our current human findings complement our previously published data on the association
between functional COMT haplotypes and sensitivity to noxious stimuli [6, 7]. As reported
previously on a separate human cohort of 202 healthy female volunteers, in this study HPS
haplotype was also associated with the highest sensitivity to noxious stimuli. Furthermore,
the association between the COMT haplotype and thermal pain sensitivity was much
stronger than with other pain modalities such as mechanical and ischemic pain. Also, overall
algometer pressure pain was not associated with COMT haplotypes [7] and, similar to this
study, only individual algometer measures obtained at specific anatomical sites reached
significance (e.g., pressure threshold at the wrist [46]). Among the measures of thermal heat
pain sensitivity, the pattern of association observed in this study is also remarkably
consistent with earlier findings [7, 46]: thermal pain threshold showed the strongest
association with the COMT haplotypes, thermal tolerance showed a weaker association, and
thermal pain temporal summation showed no association.
Likewise, similar to the results of previous studies, COMT haplotypes were significant
predictors of pain sensitivity in both thermal sensitivity and capsaicin-evoked pain assays,
but not the Val158Met SNP by itself.
Translational value of the findings
The findings from this study have a number of practical implications. First, modality- and
gender-specificity of COMT effects should be considered in clinical setting when novel
COMT-dependent analgesics are tested, such as propranolol [47, 48]. These considerations
may be relevant not only for pain research but also for other complex traits and diseases
influenced by COMT genetic variation, such as cognitive function or depression. Second,
the sex-specific differences in COMT effects on pain, demonstrated here, indicate that sex
should be considered differently when evaluating the association between COMT genetic
variation and pain perception. Regression models to evaluate the association between
COMT genetic variants and pain sensitivity may fail to detect an association even when a
covariate for sex is included in the model. Thus, it may be necessary to consider more
complex interactions or stratify by sex when performing such an analysis. It also should be
noted that the sex specific effect on pain phenotypes is rather common and not unique for
COMT [53]. Finally, other biological factors such as age, body mass index, ethnicity and
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sleep may further modify the complex relationship between COMT genetic variation and
pain. Clearly, additional research is needed to facilitate the clinical application of our
findings.
In summary, the observed specificity in the genetic effects of genes like COMT may be one
of the major reasons for difficulties in reproducing findings of genetic influences on pain.
This study not only contributes to our understanding of COMT-dependent pain sensitivity
but also provides further guidance for future genetic studies of pain.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Mouse responsiveness to 20 nociceptive assays combined into 6 pain modalities categorized
by two Comt alleles. Filled bars indicate strain carries the ComtB2i allele. Six modalities of
nociception depicted as z-scores. Increased sensitivity to pain modality is depicted by
positive z-score.
Belfer et al. Page 15














Mouse responsiveness to capsaicin-induced pain categorized by two Comt alleles. Filled
bars indicate strain carries the ComtB2i allele. The greater values reflect greater pain
sensitivity.
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Human responsiveness to capsaicin-induced pain categorized by three major COMT
haplotypes. LPS: haplotype G_C_G_G, APS: haplotype A_T_C_A, HPS: haplotype
A_C_C_G. The greater values reflect greater pain sensitivity. VAS – visual analog scale.
*P<0.05. Mean scores are adjusted for sex, age, study site, and race. Error bars reflect the
standard errors of the mean.
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